https://charts.traderzeitung.de/phases/US74365A3095
string(1405) "{"isin":"US74365A3095","name":"Protalix BioTherapeutics Inc","stock_id_xnas":null,"stock_id_xnys":10818729,"generated_at":"2026-08-21 12:23:00","days":[{"date":"2026-08-18","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":2.335,"close_at":"2026-08-18 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-08-19","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":2.345,"close_at":"2026-08-19 21:59:00","complete":true,"perf_pct":0.4283},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-08-20","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":2.375,"close_at":"2026-08-20 21:59:00","complete":true,"perf_pct":1.2793},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"
Protalix BioTherapeutics Aktie News & Nachrichten

Protalix BioTherapeutics Aktie News & Nachrichten

[WKN: A2PWSL | Symbol: PLX]
Realtimekurs
   
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel

Protalix BioTherapeutics Inc. (PLX): H.C. Wainwright sieht 533 % Kurspotenzial!

Protalix BioTherapeutics Inc. (PLX) ist ein biopharmazeutisches Unternehmen, das sich auf die Entwicklung...

  • 1